Long-term results of a randomised phase III trial of weekly versus three-weekly paclitaxel/platinum induction therapy followed by standard or extended three-weekly paclitaxel/platinum in European patients with advanced epithelial ovarian cancer
| Autor: | van der Burg, M.E.L., Onstenk, W., Boere, I.A., Look, M., Ottevanger, P.B., de Gooyer, D., Kerkhofs, L.G.M., Valster, F.A.A., Ruit, J.B., van Reisen, A.G.P.M., Goey, S.H., van der Torren, A.M.E., ten Bokkel Huinink, D., Kok, T.C., Verweij, J., van Doorn, H.C. |
|---|---|
| Zdroj: | In European Journal of Cancer October 2014 50(15):2592-2601 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect